Expansive Network QML Pathology operates a wide-reaching network with over 400 collection centers and 23 laboratories across Queensland and northern New South Wales, providing extensive service coverage that presents numerous opportunities for technology integration and service expansion.

Stable Financials With annual revenues estimated between 25 million and 50 million dollars and a solid operational scale, QML Pathology has the financial capacity to invest in advanced diagnostic tools, innovations, and expanding its service offerings.

Technological Infrastructure The company employs a modern tech stack including cloud-based services, website platforms, and security measures, indicating openness to adopting new digital solutions to improve efficiency and patient engagement.

Market Leadership As a regional leader in diagnostic testing with long-standing industry presence for over 90 years, QML Pathology is well-positioned to leverage its reputation and relationships in healthcare to adopt cutting-edge technologies and new service models.

Growth Opportunities Given the large number of daily patients and the scale of operations, there are significant opportunities to introduce innovative testing solutions, data analytics, and patient engagement platforms to enhance service capabilities and efficiency.